Howard Maibach is a board-certified dermatologist and an expert in contact and occupational dermatitis and sees patient at the Environmental Dermatosis Clinic, which is part of the Dermatology Clinic. His specialty is dermatotoxicology, or skin exposure toxicity; allergies and skin disorders; and dermatopharmacology or the study of medications for skin disorders. Dr. Maibach has been on the editorial board of more than 30 scientific journals and is a member of 19 professional societies including the American Academy of Dermatology, San Francisco Dermatological Society and the Internal Commission on Occupation Health. He is a Professor in the Department of Dermatology at UCSF.

John Pierce Wise, Sr. is a Professor and a Distinguished University Scholar and head of the Wise Laboratory of Environmental and Genetic Toxicology in the Department of Pharmacology and Toxicology at the University of Louisville School of Medicine. He is the President the International Society for Trace Element Research in Humans (ISTERH), Vice-President for the Carcinogenesis Specialty Section of Society of Toxicology (SOT), and Chair of the 2023 annual meeting of the Society of Environmental and Chemistry, North America (SETAC).He also co-directs a training program for graduate students and postdoctoral scholars emphasizing the environmental health sciences. Dr. Wise holds a B.S. with distinction and with recognition in biology from George Mason University, and a Ph.D. in pharmacology from George Washington University. His postdoctoral training focused on molecular epidemiology under Drs. Curtis Harris and Peter Shields at the National Cancer Institute (NCI), followed by training in occupational health and risk assessment as a senior toxicologist at Jonathan Borak and Company. He has served on the faculty of Yale University’s School of Medicine and School of Public Health, the University of Southern Maine, prior to joining the faculty at the University of Louisville, School of Medicine. His research interests focus how environmental toxicants affect health and cause cancer from a One Environmental Health perspective considering cellular and molecular mechanisms in both humans and wildlife, with a particular emphasis on lung cancer and chromosome instability. He has earned and managed over $20 million in grants and contracts and published more than 140 manuscripts and book chapters and over 650 abstracts. His work has been featured in numerous articles in local, national, and international press and social media sites including short documentaries with Alexandra Cousteau and Miles O’Brien. He earned the prestigious Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) R35 grant from the National Institute of Environmental Health Sciences (NIEHS). He is also the recipient of three SOT awards for Mentoring, Education, and Career Achievement in Metals and is also the recipient of the Environmental Mutagenesis and Genomics Society’s (EMGS) Education award.

Danilo Tagle is currently Director, Office of Special Initiatives at the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) where he leads efforts in developing innovative tools and technologies that can greatly accelerate development of disagnostics and therapeutics. These programs involve interdisciplinary collaborations between intramural and extramural components of NIH, and entail partnerships with other agencies, such as FDA, NASA and DARPA, as well as with private sector. Some of the programs include tissue chips, 3D bioprinting, automated chemistry, electronic nose technology for disease diagnosis, and the isolation and analyses of exosomes for biomarker and therapy development. He has served on numerous advisory and review committeesand editorial boards.He currently serves on the Biological and Physical Sciences Federal Advisory Committee, on the White House OSTP Microgravity Science and Technology Interagency Working Group, and servesas the point-of-contact for the liaison to the NASA/NIH/Department of Health and Human Services partnership. Dan obtained his PhD and MS in molecular biology and genetics from Wayne State University School of Medicine. He was an NIH National Research Service Award postdoctoral fellow in human genetics at the University of Michigan. Dan has authored many scientific publications and has garnered numerous awards, including more recently the Roscoe O. Brady Award for Innovation and Accomplishment; the Henry J. Heimlich Award for Innovative Medicine; and the HHS Secretary's Award for Distinguished Service: Rapid Acceleration of Diagnostics (RADx) Initiative.

Paulo C. DE MORAIS, PhD, was full Professor of Physics at the University of Brasilia (UnB) Brazil up to 2013, Appointed as UnB's Emeritus Professor (2014), Appointed as Guest Professor of Huazhong University of Science and Technology-China (2011), Visiting Professor at Huazhong University of Science and Technology (HUST)-China (2012-2015), Appointed as Distinguished Professor at Anhui University (AHU) -China (2016-2019), Appointed as Full Professor at Catholic University of Brasilia (UCB) -Brazil (2018), Appointed as CNPq-1A Research Fellowship since 2010, 2007 Master Research Prize from UnB, 2008-member of the European ERA NET Nanoscience Committee, Member of the IEEE-Magnetic Society Technical Committee, Senior Member of the IEEE Society, 2012 China's 1000 Foreign Expert Recipient, and 2012 Academic Excellence Award from Brazilian Professor's Union. He held two-years (1987-1988) post-doc position with Bell Communications Research -New Jersey, USA and received his Doctoral degree in Solid State Physics (1986) from the Federal University of Minas Gerais – Brazil. He graduated in both Chemistry (1976) and Physics (1977) at UnB.ProfessorMorais is member of the Brazilian Physical Society and the Institute of Electrical and Electronics Engineers -IEEE. He has served as referee for more than 50 technical journals, takes part of the Editorial Board of more than 15 technical journals and has conducted research on nanomaterials for over 40 years. He has delivered more than 150 Invited Talks all over the World. He is known for his research in preparation, characterization and applications of nanosized materials (magnetic fluid, magnetoliposome, magnetic nanoemulsion, magnetic nanocapsule, magnetic nanofilm, magnetic nanocomposite, nanosized semiconductors, polymeric dots, carbon dots, and graphene quantum dots). With nearly 500 published papers in peer reviewed journals, over 12,000 citations and 15 patents, he has appeared in recent World ranking of top 1% scientists, such as 2020-Stanford, 2022-Research.com, and 2023-AD Scientific Index.

Dr. Cai received his MD in 1983 and Ph.D. in 1990 from Jilin University, China. He has had his postdoctoral training in the University of Western Ontario and McGill University, Canada. Dr. Cai is tenured of Departments of Pediatrics, Radiation Oncology and Pharmacology and Toxicology, and Director of Pediatric Research Institute, the University of Louisville School of Medicine. Dr. Cai has served on the many special grant review panels and committees at the NIH, Department of Defense, American Diabetes Association, and American Heart Association. He has authored and co-authored more than 360 publications including peer-reviewed articles and/or book chapters, etc. He is Editor-in-Chief of Journal of Toxicology and Risk Assessment (2016-Present), Journal of Microbial & Biochemical Technology (2017-Present), and World Journal of Diabetes (2020 present), Associate Editor of Journal of Geriatric Cardiol (2011-2015), Toxicol Sci (2014- 2019), Radiation Medicine Protection (2020), Frontier in Endocrinology (specialty cardiovascular diseases, 2021-present). His research interests include but limited diabetic cardiovascular complications; impact of environmental exposure to toxic metals and chemicals; low-dose radiation hormesis; metallothionein and zinc biology.

Dr. Young is an Assistant Professor of Pharmacology and Toxicology and a Jewish Heritage Funds for Excellence Scholar at the University of Louisville. She received her doctorate in Pharmacology and Toxicology from the University of Louisville in 2020 and was a postdoctoral scholar at the University of Louisville from 2021-2022. Her research vision focuses on the role of metal-induced chromosome instability in liver disease pathogenesis and cancer, and spans molecular, cellular, animal and population-based studies with the goal of providing a platform for the creation of novel target therapies and diagnostic tools related to sex (as a biological variable) and age differences in disease etiology. Dr. Young is an active member of the Society of Toxicology (SOT) and has been recognized by the SOT Metals Specialty Section (MSS) with their Bruce A. Fowler Metals Young Investigator Award, given to an early career scientist who has made significant contributions to the field of metals toxicology, and by the SOT Women in Toxicology Special Interest Group with their Celebrating Women in Toxicology Award. Currently, Dr. Young serves as the Vice President-Elect for the SOT MSS, as a Council Member and Co-President for the 15th International Society for Trace Element Research in Humans (ISTERH) conference to be held in Murcia, Spain in October 2024, and Co-section Editor for the Metals Section of Current Environmental Health Reports.

Dr. Anja Ramisch graduated as biochemist at the Martin-Luther University of Halle/Saale. She made her PhD at the Institute of Environmental Toxicology of Martin-Luther University. In 2014, she passed the examination to become a specialist of toxicology of the German Society of Toxicology. Since 2005 she worked as regulatory toxicologist in the field of preclinical evaluation of drugs and biocompatibility assessment of medical devices. During this time, she evaluated the biological safety of different types of medical devices including for instance wound dressings, dental products, ventilators and implants. As an experienced toxicologist, she has lectured several seminars on the topic of biological safety of medical devices.

Dr. Manuela Berto Pucca is a highly accomplished scientist and researcher in the field of toxinology. With a strong background in Immunology, she holds advanced degrees and has completed postdoctoral fellowships at prestigious institutions. Dr. Pucca has published over 80 articles in renowned journals, holds patents, and has contributed to the development of biotherapeutic products. She is actively engaged in academia, serving as a professor at the Sao Paulo State University (UNESP). In addition to her extensive research, Dr. Pucca focuses on studying snakebite victims, including indigenous populations, in the Amazon region. Her dedication to understanding and addressing the impact of snakebites on vulnerable communities has earned her awards and recognition for her significant contributions to the field of toxinology, neglected tropical diseases, and immunology.

Born in Loanda, state of Parana, he is a pharmacist-biochemist from UEM (2004), specialist in Social Sciences from PUC-RS (2022), Master in Biosciences and Pathophysiology from UEM (2006) and PhD in Tropical and Infectious Diseases from UEA ( 2010). Postdoctoral fellow at the Praxis Laboratory at UFSC, in the area of Sociology of Work in Health. Improvement in Malaria Epidemiology, at ISGLOBAL/Universitat de Barcelona in 2011. Researcher at the Heitor Vieira Dourado Tropical Medicine Foundation (FMT-HVD), since 2008. Director of Teaching and Research at FMT-HVD, since 2017. Professor of Epidemiology Clinic at UEA, since 2013. Member of the permanent faculty of 2 Graduate programs: Tropical Medicine at UEA/FMT-HVD and Pharmaceutical Sciences at UFAM. Coordinator of the Graduate Program in Tropical Medicine at UEA/FMT-HVD, in the 2017-2020 quadrennium. To date, he has supervised 18 scientific initiation students, 11 master's students and 9 doctoral students. Supervised 5 postdocs. He currently supervises 2 scientific initiation students, 2 master's students and 9 doctoral students. He has experience in the field of Pathophysiology, Pharmacoepidemiology and Implementation Science in the field of Neglected Tropical Diseases, mainly in malaria and animal poisoning. He is currently principal investigator or coordinator of several research projects funded by the Bill & Melinda Gates Foundation, National Institutes of Health, Instituto Butantan, FAPEAM and CNPq, in collaboration with renowned national and international institutions. He has around 315 articles published in national and international journals. Author of book chapters on Plasmodium vivax malaria and ophidism. Reviewer of several national and international scientific journals. Member of INCT Elimination, Karma Consortium (Institute Pasteur Paris), Ivermectin Research for Malaria Elimination Network, Center for Innovation in Artificial Intelligence for Health (CIIA-UFMG) and National Pharmacogenetics Network (Refargen). Associate Editor of the journals Plos Neglected Tropical Diseases, Frontiers in Immunology, Malaria Journal and Magazine of the Brazilian Society of Tropical Medicine. He was a member of the Therapeutic Committee of the National Malaria Control Program, of the Ministry of Health. Affiliate member of the Brazilian Academy of Sciences. Member of WHO - Gap Assessment Tool for Snakebites. Ivermectin Research for Malaria Elimination Network, Center for Innovation in Artificial Intelligence for Health (CIIA-UFMG) and National Pharmacogenetic Network (Refargen). Associate Editor of the journals Plos Neglected Tropical Diseases, Frontiers in Immunology, Malaria Journal and Magazine of the Brazilian Society of Tropical Medicine. He was a member of the Therapeutic Committee of the National Malaria Control Program, of the Ministry of Health. Affiliate member of the Brazilian Academy of Sciences. Member of WHO - Gap Assessment Tool for Snakebites. Ivermectin Research for Malaria Elimination Network, Center for Innovation in Artificial Intelligence for Health (CIIA-UFMG) and National Pharmacogenetics Network (Refargen). Associate Editor of the journals Plos Neglected Tropical Diseases, Frontiers in Immunology, Malaria Journal and Magazine of the Brazilian Society of Tropical Medicine. He was a member of the Therapeutic Committee of the National Malaria Control Program, of the Ministry of Health. Affiliate member of the Brazilian Academy of Sciences. Member of WHO - Gap Assessment Tool for Snakebites. Malaria Journal and Magazine of the Brazilian Society of Tropical Medicine. He was a member of the Therapeutic Committee of the National Malaria Control Program, of the Ministry of Health. Affiliate member of the Brazilian Academy of Sciences. Member of WHO - Gap Assessment Tool for Snakebites. Malaria Journal and Magazine of the Brazilian Society of Tropical Medicine. He was a member of the Therapeutic Committee of the National Malaria Control Program, of the Ministry of Health. Affiliate member of the Brazilian Academy of Sciences. Member of WHO - Gap Assessment Tool for Snakebites

Dr. Jacqueline De Almeida Goncalves Sachett is a professor of postgraduate education at the State University of Amazonas in collaboration with the Fundacao de Medicina Tropical-Doutor Heitor Vieira Dourado. Dr. Jacqueline is mentor master's and doctoral students who focus mainly on the decentralization of antivenom in urban, rural, and indigenous areas of Brazil. Dra. Jacqueline has experience with innovation and works in the development of pharmaceutical products in partnership with private companies. Dr. Jacqueline has experience in nursing, working mainly on the following topics: venomous animals, nephrology and dermatology.

He holds the title of Medical Doctor with specialized training in Infectious Diseases and Tropical Medicine. At present, he is deeply engaged at the General Hospital of Roraima (HGR), where his primary focus revolves around patients with infectious diseases, specifically addressing cases such as HIV/AIDS, viral hepatitis, and snakebite management. Concurrently, he serves as a professor at the School of Medicine at UFRR. Additionally, he assumes the esteemed roles of Founding President and Director at the Infectious Diseases Association of the State of Roraima (AIERR) and dedicates his efforts as a Researcher at the Clinical Research Center (CECOR).

Dr. Roberto Carlos C. Carbobell was Born in Pinal Del Rio, Cuba in 1982. Graduated medical school from my mainland in 2007. Started epidemiological surveillance in Brazil where he later did his infectious disease residency that he completed in 2014. He completed His master's degree in health sciences from the Federal University of Roraima (UFRR). Dedicated seven years of his career to the state referral outpatient clinic for tuberculosis. Currently a full-time physician at the general hospital of Roraima, professor of infectious disease in the Federal university Roraima (UFRR), and head of the infectious Diseases and Tropical Medicine clinic at UFRR.

Dr. Felipe Cerni holds a Bachelor's degree in Biological Sciences and earned both his Master's and Ph.D. in Sciences with a focus on Toxicology from the Faculty of Pharmaceutical Sciences at the University of Sao Paulo - USP. During his Master's and Ph.D. He conducted internships abroad at Katholieke Universiteit Leuven - KULeuven in Belgium. Dr. Cerni also completed two postdoctoral fellowships at the Department of Biomolecular Sciences, Faculty of Pharmaceutical Sciences, University of Sao Paulo - USP, and another postdoctoral fellowship at the Technical University of Denmark in Denmark. Additionally, he served as a visiting professor and Postgraduate supervisor at the Graduate Program in Health Sciences - PROCISA at the Federal University of Roraima - UFRR. Currently, Dr. Felipe Cerni is conducting a postdoctoral research program in collaboration with the Heitor Vieira Dourado Tropical Medicine Foundation at the State University of Manaus. Moreover, he is a co-founder of the startup Zeta Venom, which was ranked among the top 24 Brazilian startups in 2023 in the "Like a Boss" program by SEBRAE. Dr. Cerni has extensive experience in various areas such as Toxicology, Parasitology, Immunology, Electrophysiology, Bioprospecting, Biochemistry, Epidemiology, and Innovation. His research is mainly dedicated to studying Neglected Diseases in indigenous communities, Venomous Animals, Animal Venoms, Neurotoxins of animal origin, Antivenoms, and Phage Display.

Dr. Oliveira is a biomedical scientist who earned her degree at the Federal University of TrianguloMineiro (UFTM, Brazil). She pursued her passion for research by completing her master's and PhD in Toxicology at the School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo (FCFRP/USP, Brazil). During her PhD studies, she had the valuable opportunity to conduct part of her research at the Universite de Liege (Belgium) and the Technical University of Denmark (Denmark). Currently, Dr. Oliveira holds a prestigious postdoctoral position at FCFRP/USP, where she dedicates a significant portion of her research to international collaborations. Her work primarily focuses on cutting-edge techniques for the production of recombinant monoclonal antibodies. Her expertise spans across several interdisciplinary fields, including Biochemistry, Toxicology, Toxinology, and Immunology. She has made notable contributions in areas such as animal venoms, the isolation and characterization of animal toxins, mass spectrometry, proteomics, antivenoms, and animal toxins as therapeutic agents.

Born in 1960 in Marseille, France, He started study medicinein 1978 and passed doctoratein 1992. Firstly specialized in epidemiology and public health, He quickly changed his way to become intensivist in 1996 with a subspecialty in clinical toxicology. During his carrier he was head of a Intensive Care and Toxicology Unit in the area of Bordeaux, France. He is a member of the European Association of Poison Centers and Clinical toxicologists (EAPCCT). He is retired since January 2023 and was promoted Emeritus Member of the EAPCCT the same year. He have published several papers on toxicology, and especially on natural toxins.

Henriqueta Louro, research scientist. With a background in Biochemistry and a PhD in Public Health, Henriqueta Louro investigates the impact of xenobiotics from environmental and occupational settings on the human genome. She has worked in the analysis of genotoxic effects of chemical or physical agents in vitro and in vivo. She is also involved in human biomonitoring studies, namely to investigate the biological effects of chemical exposure. She participates in the recently started Partnership for the Risk Assessment of Chemicals (PARC) and her work involves nanotoxicology, with participation in European projects (Nanogenotox and NanoReg) as well as in national projects. She is an external member on working groups at European Food Safety Agency(EFSA) and Scientific Committee on Consumer Safety .

Prof Begum Rokeya is a medical graduate and completed her PhD from Kyev Institute of Pharmacology and Toxicology, Ukraine. She has vast research experience in the arena of antidiabetic plants and herbal medicine. Her main Research focuses on plant materials as a source of new antidiabetic agents.Shehas got good numbers of research projects from home and abroad. Prof Rokeyais also working as the Network Leader of Asian Network of Research on Antidiabetic Plants (ANRAP) and Deputy Network Leader of Network of Instrument Technical personnel and User scientists of Bangladesh (NITUB). is the member of a number of scientific societies.

Prof. Dr. Raafat Abdeldayem is an emeritus consultant (emeritus Professor), Emergency Hospital- Faculty of Medicine, Mansoura University, Egypt. PhD of hydro-geochemistry in 2004, at Mansoura University and previously completed an MSc of hydro-geochemistry in 2001 at the same institution. Toxicology and forensic chemistry post-graduate diploma (1996), faculty of medicine Applied chemistry post-graduate diploma (1993) Specializes in toxicology & forensic chemistry, water pollution as well as medical analyses. Published papers over 19 local and 11 international publications. Spoken at 78 local and 18 international conferences and workshop. Currently member of eight international scientific societies

Dr. Ying Peng is working in Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University as a full-professor. His current research field include: 1. Prevention and Treatment of Cerebrovascular Disease. 2.Brain injure and neural regeneration. He got 13 grants after working in the Sun Yat-Sen Memorial Hospital. He published 150 papers in SCI journals. Additionally, he got the Fellows Award for Research Excellence 2001, sponsored by National Institutes of Health of USA., the Second Prize for Scientific Technique Progress Award of Guangdong Province 2014 and the First Prize for Medical Scientific Technique Progress Award of Guangdong Province 2021 in China.

Dr Ng Mingwei graduated from Yong Loo Lin School of Medicine, National University of Singapore with his M.B.B.S. in 2014. He attained his postgraduate qualifications (Masters of Medicine (Emergency Medicine)) from National University of Singapore in 2018. He was recognized as a Specialist in Emergency Medicine since 2021 and currently practises as a Consultant in Singapore General Hospital Department of Emergency Medicine. His subspecialty interests lie in emergency medical toxicology, disaster medicine and engaging young minds through medical education. He is a Fellow with the SingHealth Toxicology Service and also serves as Assistant Commander for Disaster Site Medical Command in the Ministry of Health, Singapore.

coming soon...

Idoia Meaza is a PhD candidate at the University of Louisville in the Wise Laboratory of Environmental and Genetic Toxicology, where she is studying the mechanism of hexavalent chromium [Cr(VI)]-induced carcinogenesis. Prior to joining the Ph.D. program at the University of Louisville, Ms. Meaza received a competitive Erasmus Mundus scholarship to complete an international Master’s degree. She completed her master thesis in the program with John Pierce Wise, Sr., head of the Wise Laboratory at the University of Louisville. She has continued in Dr. Wise´s laboratory pursuing a Ph.D. in Pharmacology and Toxicology. Idoia has received many awards for her research and communication skills. For example, this year, she has received a prestigious LaCaixa Fellowship to support her during her PhD candidacy as well as the Department of Pharmacology and Toxicology outstanding graduate student award, the “K.C. Huang Award”. Idoia is a highly motivated student, she has extensive experience in leadership, service and research. She is interested in investigating how environmental toxicants induce genomic changes that can lead to disease and how we can prevent them. At the moment, she is studying how Cr(VI) causes chromosome instability and DNA double strand break inhibition, and how these lead to the development of lung cancer.

Aggie Williams isa PhD candidate in the department of pharmacology and Toxicology at the University of Louisville. She studies under the supervision of Dr. John Pierce Wise, Sr in the Wise Laboratory of Environmental and Genetic Toxicology. Her workfocuses on an in-depth investigation into the mechanism of how hexavalent chromium affects human, animal,and environmental health. Aggie has received many awards for her research including the Bristol Myers Squibb research training award, Environmental Carcinogenesis Merit Award, Toxicologists of African Origin research for graduate students. Aggie is an active student leader leader serving as the student representative for the Metals Specialty Section of Society of Toxicology (SOT). Hrerresearch is building on the observations that hexavalent chromium disrupts the major break repair pathway, homologous recombination (HR) repair pathway.

Coming soon...

Dr Nadjia BEKKARI a lecturer researcher from Algeria; she is graduated in Biochemistry; she is a highly accomplished scientist and researcher in the field of toxicology. With a strong background in Immunology. Dr BEKKARI focuses on studying beneficial effects of components from animal venoms on cancers. Her dedication to explore molecular mechanism of toxicity and also addressing molecular target of venom components on cancers experimental model.

My research area focuses on statistical mechanics of biological macromoleculese. e.g, proteins, nucleic acids, membranes, and drugs. A major effort has been on the development and application of computer models and simulation methods for molecular systems. Particular research problems include study of atomic mobility in proteins and membranes by molecular dynamics and Monte Carlo computer simulations; quantitative modeling of recognition and binding in ligand-receptor systems with solvation effects; development of methods for computing free energy change efficiently in solution phase processes; calculation of diffusion constants and diffusion encounter rates of rigid and flexible molecules in solution and onto biomembranes by Brownian dynamics simulations; modeling of subcellular and cellular processes, including signal transduction, gene expression, and cytoskeletal dynamics.

Coming Soon...

coming soon..